Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
69 /100
HIGH RISK
Score updated Oct 13, 2026

VTGN — Vistagen Therapeutics, Inc. Dilution Risk Tracker

Track VTGN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VTGN — Get alerts when the score changes →

As of October 13, 2026, Vistagen Therapeutics, Inc. (VTGN) has a DilutionWatch DilutionScore of 69/100, rated HIGH dilution risk. Vistagen Therapeutics, Inc. has a market capitalization of $10.06M, 44.38M shares outstanding, 59 institutional holders tracked. Stored dilution-related fields include 20.56M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
85
📊 Float Risk
40
⚠️ Warrant Exposure
90
🔄 Convertible Debt
85

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 65%
🔄 Reverse Split model est. 70%
• 50-day avg $0.61 below $1 exchange minimum
• Only 4 months cash — financial pressure
📜 Warrant Exercise model 60%
• Massive warrant overhang: 46% of shares outstanding
• Warrant risk score very high (90/100)
🔁 Convertible Conversion model 60%
• Major convertible overhang: 329% potential dilution
• Convertible risk score very high (85/100)
🔔 Track VTGN — Get forecast alerts →

Market Data

Market Cap$10.06M
Shares Outstanding44.38M
Float34.38M
Cash$16.99M
Debt$-1.51M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore69/100DilutionWatch score record
Shares Outstanding44.38MVerified float table or market cache
Public Float34.38MVerified float table or market cache
Market Cap$10.06MMarket data cache
Cash Runway3.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants20.56MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 4, 8-K 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.7% shares (2026Q1 vs prior)
59 institutional holders · 17.64M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 3.15M shares
#2 ORBIMED ADVISORS LLC 3.06M shares
#3 TCG Crossover Management, LLC 2.68M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.75M
Days to Cover1.0
% of Float10.9%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-14
xbrl XBRL CONVERTIBLE 2017-06-29
8-K 8K EVENT 2026-04-13
4 INSIDER TRANSACTION 2026-04-09
4 INSIDER TRANSACTION 2026-04-09
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual VTGN Dilution Snapshot

Vistagen Therapeutics, Inc. (VTGN) has a DilutionScore of 69/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

VTGN's DilutionScore is currently 69/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 70/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202669/100HIGH13 days
Aug 22 – Sep 30, 202670/100HIGH40 days
Aug 14 – Aug 21, 202648/100MEDIUM7 days
Jul 16 – Aug 13, 202662/100HIGH29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track VTGN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment VTGN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking VTGN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for VTGN
VTGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.